AstraZeneca announces that Truqap in combination with Faslodex has been recommended by the Committee for Medicinal Products for Human Use of the European Medicines Agency for approval in the.
For the first time, a study has detected tumor DNA in the breast milk of patients with breast cancer. The researchers involved propose a liquid biopsy of this fluid, as a tool for early diagnosis of the disease
AUSTIN, Texas and BARCELONA, Spain, Feb. 15, 2022 (SEND2PRESS NEWSWIRE) Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a research collaboration with Vall d'Hebron Barcelona Hospital Campus to develop new technologies for B-cell monitoring in transplant rejection. - News from Pure Transplant Solutions LLC, issued by Send2Press Newswire
Pure Transplant Solutions and Vall d Hebron University Hospital Announce Research Collaboration on Transplant Rejection massachusettsnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from massachusettsnewswire.com Daily Mail and Mail on Sunday newspapers.
eNewsChannels NEWS: Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a research collaboration with Vall d'Hebron Barcelona Hospital Campus to develop new technologies for B-cell monitoring in transplant rejection. :: News from eNewsChannels